- Home
- Applications
- biomark
Refine by
Biomark Product Applications For The Served Medical Health Care Industry
18 applications found
Measuring mRNA transcript abundance with RNASeq methods offers clinical researchers a powerful platform to examine changes in the expression levels of multiple biomarkers. The power of targeted RNASeq lies in its ability to count the number of reads of a given transcript in a sample as a surrogate for expression level, much like a digital PCR system but able to measure 100s of biomarkers simultaneously. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Combine high sensitivity biomarker testing with traditional blood gas and ...
ByProxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA)
Discover autoantigens in autoimmune diseases, delineate new candidate biomarkers. Autoantibodies are present in the blood of all healthy individuals. However, when directed at high levels against protein targets in specific tissues, autoantibodies can be a major cause of autoimmune diseases. They are also important biomarkers for diagnosis of these conditions. ...
ByCambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM
Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. ...
ByMetabogen AB based in Stockholm, SWEDEN
Robovision can provide or develop powerful tools to enhance the detection, classification, and quantification of lesions or ...
ByRobovision BV based in Ghent, BELGIUM
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Kirkstall’s Quasi Vivo® system aims to establish and optimise a human in vitro 3D Blood Brain Barrier (BBB) in an effort to identify important mechanistic pathways for successful biomarker analysis, drug delivery and toxicity ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
Reading for DNA Digital Data Storage: Unprecedented amounts of data are being generated by new technologies - from Internet of Things sensors to ubiquitous digital devices - with the unintended consequence that data production will outpace our ability to store it efficiently. Next-generation digital data storage is critical. New solutions that are ultra-dense and ultra-durable are required. By converting binary data into synthetic DNA sequences, we could harness the power of DNA to store data efficiently and at ...
ByRoswell Biotechnologies Inc based in San Diego, CALIFORNIA (USA)
Sepsis is one of the leading causes of death worldwide. It is a life-threatening condition caused by a dysregulated host response to infection, which can progress to multiple organ dysfunction, septic shock and even death 1. Every hour counts in sepsis. It’s a medical emergency that requires immediate diagnosis because any delay in treatment can dramatically reduce the chances of survival 2. ...
ByAbionic SA based in Epalinges, SWITZERLAND
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
An electrical stimulation, i.e., action potential initiates cardiac contraction. Intracellular Ca2+-transient couples action potential and cardiac contraction. Cardiac contraction is also coupled to mitochondria that replenish energy (i.e., ATP) and recycle metabolites (ADP and Pi). InvivoSciences analyzes all those parameters to determine drug-induced or genetically driven changes in ECE ...
ByInvivoSciences, Inc. (IVS) based in Madison, WISCONSIN (USA)
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
Laser Force Cytology (LFC) and Radiance label-free approach to cell therapy research and biomanufacturing has significant value in expediting the process, decreasing costs, and ensuring therapy effectiveness and quality. Radiance enhances the highly complex biomanufacturing process for cell therapies by providing new insights to cell therapy research and process development. Current process development assays are fraught with difficult and time-consuming steps requiring highly skilled scientists and bioengineers ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Iconeus is leveraging its expertise in preclinical research to develop innovative clinical applications using its Iconeus One CR functional ultrasound system. This system is instrumental for transcranial ultrasound localization microscopy (ULM), allowing for the imaging of the brain's microvasculature at a microscopic resolution, which is particularly beneficial for diagnosing and monitoring stroke and aneurysm. The system's current projects, in collaboration with entities like Geneva University and Physics for ...
ByIconeus based in Paris, FRANCE